Oct 22, 2023 / 04:30PM GMT
Presentation Call
Oct 22, 2023 / 04:30PM GMT
=====================
Corporate Participants
=====================
* Erin Graves
Revolution Medicines, Inc. - Senior Director of Corporate Communications & IR
* Margaret A. Horn
Revolution Medicines, Inc. - COO
* Mark A. Goldsmith
Revolution Medicines, Inc. - CEO, President & Chairman
* Stephen M. Kelsey
Revolution Medicines, Inc. - President of Research & Development
* Wei Lin
Revolution Medicines, Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Alec Warren Stranahan
BofA Securities, Research Division - Associate
* Ami Fadia
Needham & Company, LLC, Research Division - Senior Analyst
* Benjamin Jay Burnett
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
* Charles S. Ferranti
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Eric William Joseph
JPMorgan Chase & Co,
Revolution Medicines Inc
(NAS:RVMD)
$
59.1
-0.32 (-0.54%)
Market Cap: 9.94 Bil
Enterprise Value: 8.42 Bil
PE Ratio: 0
PB Ratio: 6.08
GF Score: 41/100 Revolution Medicines Inc To Discuss ESMO Data Presentation Call Transcript
Oct 22, 2023 / 04:30PM GMT
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot